[Clinical trials of chemotherapy and chemoimmunotherapy of malignant melanoma with unfavorable prognosis after surgical treatment].
D000276:Adjuvants, Immunologic; D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008297:Male; D008545:Melanoma / Q000601:surgery / Q000628:therapy*; D008875:Middle Aged; D011344:Procarbazine / Q000008:administration & dosage; D011379:Prognosis; D012878:Skin Neoplasms / Q000601:surgery / Q000628:therapy*; D014747:Vinblastine / Q000008:administration & dosage; D015054:Zymosan / Q000008:administration & dosage*
D000276:Adjuvants, Immunologic; D011344:Procarbazine; D014747:Vinblastine; D003520:Cyclophosphamide; D015054:Zymosan
Próby chemioterapii i chemioimmunoterapii przypadków czerniaka złośliwego z rokowniczo niekorzystnymi czynnikami po leczeniu operacyjnym.